Amir Sharafkhaneh

Summary

Affiliation: Baylor College of Medicine
Country: USA

Publications

  1. ncbi Association of psychiatric disorders and sleep apnea in a large cohort
    Amir Sharafkhaneh
    Department of Medicine at Baylor College of Medicine, VAMC Sleep Center, Houston, TX 77030, USA
    Sleep 28:1405-11. 2005
  2. ncbi The potential role of natural agents in treatment of airway inflammation
    Amir Sharafkhaneh
    MED VA Medical Center, Bldg 100 111i, 2002 Holcombe Blvd, Houston, TX 77030, USA
    Ther Adv Respir Dis 1:105-20. 2007
  3. ncbi Effect of atrial overdrive pacing on obstructive sleep apnea in patients with systolic heart failure
    Amir Sharafkhaneh
    Department of Medicine at Baylor College of Medicine, Houston, TX, USA
    Sleep Med 8:31-6. 2007
  4. ncbi The confounding effects of thoracic gas compression on measurement of acute bronchodilator response
    Amir Sharafkhaneh
    Baylor College of Medicine, MED VAMC, Bldg 100 111i, Houston, TX 77030, USA
    Am J Respir Crit Care Med 175:330-5. 2007
  5. ncbi Budesonide/formoterol combination in COPD: a US perspective
    Amir Sharafkhaneh
    Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA
    Int J Chron Obstruct Pulmon Dis 5:357-66. 2010
  6. ncbi Sleep disorders and their management in patients with COPD
    Amir Sharafkhaneh
    Baylor College of Medicine, Sleep Disorders and Research Center, Michael E DeBakey VA Medical Center, Houston TX, USA
    Ther Adv Respir Dis 3:309-18. 2009
  7. ncbi Overview of the perioperative management of lung volume reduction surgery patients
    Amir Sharafkhaneh
    Division of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, TX 77030, USA
    Proc Am Thorac Soc 5:438-41. 2008
  8. ncbi Pathogenesis of emphysema: from the bench to the bedside
    Amir Sharafkhaneh
    Division of Pulmonary, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, TX 77030, USA
    Proc Am Thorac Soc 5:475-7. 2008
  9. ncbi Sleep apnea in a high risk population: a study of Veterans Health Administration beneficiaries
    Amir Sharafkhaneh
    VAMC Sleep Center 111i, Baylor College of Medicine, 2002 Holcombe Blvd, Houston, TX 77030, USA
    Sleep Med 5:345-50. 2004
  10. ncbi Altered thoracic gas compression contributes to improvement in spirometry with lung volume reduction surgery
    A Sharafkhaneh
    Assistant Baylor College of Medicine, MED VAMC, 2002 Holcombe Blvd, Houston, Texas 77030, USA
    Thorax 60:288-92. 2005

Detail Information

Publications47

  1. ncbi Association of psychiatric disorders and sleep apnea in a large cohort
    Amir Sharafkhaneh
    Department of Medicine at Baylor College of Medicine, VAMC Sleep Center, Houston, TX 77030, USA
    Sleep 28:1405-11. 2005
    ..We conducted the present study to determine whether psychiatric disorders are commonly associated with sleep apnea in Veterans Health Administration beneficiaries...
  2. ncbi The potential role of natural agents in treatment of airway inflammation
    Amir Sharafkhaneh
    MED VA Medical Center, Bldg 100 111i, 2002 Holcombe Blvd, Houston, TX 77030, USA
    Ther Adv Respir Dis 1:105-20. 2007
    ..This review provides an overview of the literature related to the anti-inflammatory effects of some of the natural agents which have potential value in the treatment of inflammatory lung diseases...
  3. ncbi Effect of atrial overdrive pacing on obstructive sleep apnea in patients with systolic heart failure
    Amir Sharafkhaneh
    Department of Medicine at Baylor College of Medicine, Houston, TX, USA
    Sleep Med 8:31-6. 2007
    ..To further investigate this relationship, we conducted a randomized clinical trial evaluating the effect of atrial overdrive pacing on sleep-related breathing events in subjects with OSA and systolic heart failure...
  4. ncbi The confounding effects of thoracic gas compression on measurement of acute bronchodilator response
    Amir Sharafkhaneh
    Baylor College of Medicine, MED VAMC, Bldg 100 111i, Houston, TX 77030, USA
    Am J Respir Crit Care Med 175:330-5. 2007
    ..Improvement in FEV(1) is a main endpoint in clinical trials assessing the efficacy of bronchodilators. However, the effect of bronchodilators on maximal expiratory flow may be confounded by thoracic gas compression (TGC)...
  5. ncbi Budesonide/formoterol combination in COPD: a US perspective
    Amir Sharafkhaneh
    Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA
    Int J Chron Obstruct Pulmon Dis 5:357-66. 2010
    ..In this review, we evaluate available data of the efficacy and safety of this combination in patients with COPD...
  6. ncbi Sleep disorders and their management in patients with COPD
    Amir Sharafkhaneh
    Baylor College of Medicine, Sleep Disorders and Research Center, Michael E DeBakey VA Medical Center, Houston TX, USA
    Ther Adv Respir Dis 3:309-18. 2009
    ..In this publication, we review respiratory physiology as it relates to sleep and discuss sleep disorders and their management in patients with COPD...
  7. ncbi Overview of the perioperative management of lung volume reduction surgery patients
    Amir Sharafkhaneh
    Division of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, TX 77030, USA
    Proc Am Thorac Soc 5:438-41. 2008
    ..Aggressive management of early postoperative complications, including air leaks, respiratory failure, arrhythmias, and hemorrhage, can also be expected to improve outcomes...
  8. ncbi Pathogenesis of emphysema: from the bench to the bedside
    Amir Sharafkhaneh
    Division of Pulmonary, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, TX 77030, USA
    Proc Am Thorac Soc 5:475-7. 2008
    ..Identification of cellular and molecular mechanisms of COPD pathogenesis is an area of active, ongoing research that may help to determine therapeutic targets for emphysema...
  9. ncbi Sleep apnea in a high risk population: a study of Veterans Health Administration beneficiaries
    Amir Sharafkhaneh
    VAMC Sleep Center 111i, Baylor College of Medicine, 2002 Holcombe Blvd, Houston, TX 77030, USA
    Sleep Med 5:345-50. 2004
    ....
  10. ncbi Altered thoracic gas compression contributes to improvement in spirometry with lung volume reduction surgery
    A Sharafkhaneh
    Assistant Baylor College of Medicine, MED VAMC, 2002 Holcombe Blvd, Houston, Texas 77030, USA
    Thorax 60:288-92. 2005
    ..A study was conducted to determine the effect of LVRS on TGC and the extent to which reduced TGC contributed to an improvement in forced expiratory volume in 1 second (FEV1) following LVRS...
  11. ncbi Contextual factors and perceived self-reported sleepiness: a preliminary report
    Amir Sharafkhaneh
    Sleep Disorders and Research Center, Veterans Affairs Medical Center and Baylor College of Medicine, Sleep Center 116A, 2002 Holcombe Boulevard, Houston, TX 77030, USA
    Sleep Med 4:327-31. 2003
    ..g. watching television), does the respondent's position, location, or interest in the activity alter sleepiness rating. We also evaluated interactions between an individual's level of sleepiness and the effect of these contextual factors...
  12. ncbi Yield of transbronchial needle aspiration in diagnosis of mediastinal lesions
    Amir Sharafkhaneh
    Division of Pulmonary and Critical Care Medicine, Baylor College of Medicine and Houston Veterans Affairs Medical Center, Building 100 111i, 2002 Holcombe Boulevard, Houston, TX 77030, USA
    Chest 124:2131-5. 2003
    ..To determine the transbronchial needle aspiration (TBNA) yield for procedures performed by fellows in training, and the predictors of positive TBNA yield at our center...
  13. ncbi Novel method for measuring effects of gas compression on expiratory flow
    Amir Sharafkhaneh
    Michael E DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas 77030, USA
    Am J Physiol Regul Integr Comp Physiol 287:R479-84. 2004
    ..05). Furthermore, variability of NFEV(1) measurements over 6 mo was <5%. We concluded that our method reliably measures the effect of gas compression on expiratory flow...
  14. ncbi Predictors of mortality in patients with emphysema and severe airflow obstruction
    Fernando J Martinez
    Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, MI 48109 0360, and Section of Thoracic Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA
    Am J Respir Crit Care Med 173:1326-34. 2006
    ..Limited data exist describing risk factors for mortality in patients having predominantly emphysema...
  15. ncbi Continuous oxygen use in nonhypoxemic emphysema patients identifies a high-risk subset of patients: retrospective analysis of the National Emphysema Treatment Trial
    Michael B Drummond
    Division of Pulmonary and Critical Care Medicine, The Johns Hopkins University School of Medicine, 5501 Hopkins Bayview Circle, Baltimore, MD 21224, USA
    Chest 134:497-506. 2008
    ..Little is known regarding the clinical characteristics and survival of nonhypoxemic emphysema patients using continuous oxygen. Analysis of data from the National Emphysema Treatment Trial (NETT) offers insight into this population...
  16. ncbi Physical activity, health status and risk of hospitalization in patients with severe chronic obstructive pulmonary disease
    Roberto P Benzo
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Respiration 80:10-8. 2010
    ..Self-reported daily physical activity and health status have been reported as predictors of a hospitalization in COPD but are not routinely assessed...
  17. ncbi Physiological and computed tomographic predictors of outcome from lung volume reduction surgery
    George R Washko
    Pulmonary and Critical Care Division, Department of Medicine, Brigham and Women s Hospital, Boston, MA 02115, USA
    Am J Respir Crit Care Med 181:494-500. 2010
    ..We therefore sought to examine radiographic and physiologic predictors of surgical outcomes in a large, multicenter clinical investigation, the National Emphysema Treatment Trial...
  18. ncbi Effect of budesonide/formoterol pMDI on COPD exacerbations: a double-blind, randomized study
    Amir Sharafkhaneh
    Section of Pulmonary, Critical Care and Sleep Medicine, Baylor College of Medicine and Michael E DeBakey VA Medical Center Bldg 100 111i, Houston, TX 77030, USA
    Respir Med 106:257-68. 2012
    ..This randomized, double-blind, double-dummy, parallel-group, 12-month multicenter study evaluated the effect of budesonide/formoterol pressurized metered-dose inhaler (pMDI) on COPD exacerbations...
  19. ncbi Perfusion scintigraphy and patient selection for lung volume reduction surgery
    Divay Chandra
    Division of Pulmonary and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA
    Am J Respir Crit Care Med 182:937-46. 2010
    ..It is unclear if lung perfusion can predict response to lung volume reduction surgery (LVRS)...
  20. ncbi Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial
    Nicola A Hanania
    Section of Pulmonary, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, TX, USA
    Respir Res 12:6. 2011
    ..Debate continues as to whether acute bronchodilator responsiveness (BDR) predicts long-term outcomes in COPD. Furthermore, there is no consensus on a threshold for BDR...
  21. ncbi The role of intrinsic efficacy in determining response to a beta2-agonist in acute severe asthma
    Nicola A Hanania
    Department of Medicine, Baylor College of Medicine, Houston, TX, USA
    Respir Med 101:1007-14. 2007
    ..Current guidelines recommend repeated doses of albuterol for the emergency treatment of acute asthma. However, approximately one-third of patients show little or no initial response to this partial beta(2)-agonist...
  22. ncbi Variability of spirometry in chronic obstructive pulmonary disease: results from two clinical trials
    Laura B Herpel
    The Johns Hopkins University School of Medicine, Division of Pulmonary and Critical Care Medicine, 5501 Hopkins Bayview Circle, Baltimore, MD 21224, USA
    Am J Respir Crit Care Med 173:1106-13. 2006
    ..This may be applied to determine criteria that can be used to assess a clinically meaningful change in spirometry...
  23. ncbi Clinical and technologic approaches to sleep evaluation
    Max Hirshkowitz
    Department of Psychiatry, Baylor College of Medicine, Houston, Texas, USA
    Neurol Clin 23:991-1005, v-vi. 2005
    ..Finally, the mechanisms governing sleep and wakefulness are reviewed and a model of normal sleep mechanisms going awry is outlined as an aid for understanding abnormal sleep associated with sleep disorders...
  24. ncbi Pharmacotherapy of obstructive sleep apnea
    Gnananadh Jayaraman
    Department of Medicine, Baylor College of Medicine and Michael E DeBakey VA Medical Center, Houston, TX, USA
    Ther Adv Respir Dis 2:375-86. 2008
    ..In this paper we review the outcome data from published trials designed to evaluate efficacy and safety of various medications proposed for treating obstructive sleep apnea...
  25. ncbi Computed tomographic-based quantification of emphysema and correlation to pulmonary function and mechanics
    George R Washko
    Brigham and Women s Hospital, Division of Pulmonary and Critical Care Medicine, Boston, Massachusetts 02115, USA
    COPD 5:177-86. 2008
    ..The CT based quantification of emphysema may augment pulmonary function testing in the characterization of COPD by providing complementary phenotypic information...
  26. ncbi Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort
    Nicola A Hanania
    Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, TX 77030, USA
    Am J Respir Crit Care Med 183:604-11. 2011
    ..Depression is prevalent in patients with chronic obstructive pulmonary disease (COPD); however, its etiology and relationship to the clinical features of COPD are not well understood...
  27. ncbi Sex differences in severe pulmonary emphysema
    Fernando J Martinez
    University of Michigan, Division of Pulmonary and Critical Care Medicine, Ann Arbor, Michigan 48109 0360, USA
    Am J Respir Crit Care Med 176:243-52. 2007
    ..Limited data on sex differences in advanced COPD are available...
  28. ncbi Weight and metabolic effects of CPAP in obstructive sleep apnea patients with obesity
    Jose M Garcia
    Division of Pulmonary, Critical Care and Sleep Medicine, Michael E DeBakey Veterans Affairs Medical Center, 2002 Holcombe Blvd, Houston, TX 77025, USA
    Respir Res 12:80. 2011
    ..We postulated that CPAP will decrease IR, ghrelin and resistin and increase adiponectin levels in this setting...
  29. ncbi Oxygen therapy in chronic obstructive pulmonary disease
    Victor Kim
    Division of Pulmonary and Critical Care Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA
    Proc Am Thorac Soc 5:513-8. 2008
    ..The goals of this article are to briefly describe the indications for chronic oxygen administration, the physiologic effects of treatment, and potential toxicities, as well as its effect on morbidity and mortality...
  30. ncbi Integrating health status and survival data: the palliative effect of lung volume reduction surgery
    Roberto Benzo
    Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota 55902, USA
    Am J Respir Crit Care Med 180:239-46. 2009
    ..This practice tends to inflate the apparent benefits of interventions with a high risk of mortality. Assessing a composite QoL-death outcome is a potential solution to this problem...
  31. ncbi Exhaled nitric oxide parameters and functional capacity in chronic obstructive pulmonary disease
    Matthew R McCurdy
    Rice Quantum Institute, Rice University, Houston, TX, USA
    J Breath Res 5:016003. 2011
    ..56, p = 0.05). In this study of subjects with severe COPD, peripheral nitric oxide correlated with functional capacity while large airway NO parameters correlated with symptom scores...
  32. ncbi Physiologic basis for improved pulmonary function after lung volume reduction
    Henry E Fessler
    Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    Proc Am Thorac Soc 5:416-20. 2008
    ..Understanding of the mechanisms of improved function after LVRS can help select patients more likely to benefit from this approach...
  33. ncbi Burden of COPD in a government health care system: a retrospective observational study using data from the US Veterans Affairs population
    Amir Sharafkhaneh
    Baylor College of Medicine, Houston, TX, USA
    Int J Chron Obstruct Pulmon Dis 5:125-32. 2010
    ..Health care utilization and costs among US veterans with chronic obstructive pulmonary disease (COPD) were compared with those in veterans without COPD...
  34. ncbi Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression
    Jeffrey A Cully
    Houston Center Quality of Care and Utilization Studies, Dept of Psychiatry and Behavioral Sciences, Houston, TX, USA
    Psychosomatics 47:312-9. 2006
    ..When comorbid with COPD, mental health symptoms of depression and anxiety are some of the most salient factors associated with quality-of-life outcomes...
  35. ncbi Update on the pharmacologic therapy for chronic obstructive pulmonary disease
    Nicola A Hanania
    Asthma Clinical Research Center, Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, 1504 Taub Loop, Houston, TX 77030, USA
    Clin Chest Med 28:589-607, vi-vii. 2007
    ..Combining a long-acting beta-agonist with an inhaled corticosteroid is more effective than either agent alone. Several novel therapies are in different stages of development...
  36. ncbi Longitudinal change in the BODE index predicts mortality in severe emphysema
    Fernando J Martinez
    Division of Pulmonary and Critical Care Medicine, University of Michigan Medical Center, Ann Arbor, Michigan 48109 0360, USA
    Am J Respir Crit Care Med 178:491-9. 2008
    ..We hypothesized that decrease in a modified BODE (mBODE) would predict survival in National Emphysema Treatment Trial (NETT) patients...
  37. ncbi Relationship between pathologic characteristics of peripheral airways and outcome after lung volume reduction surgery in severe chronic obstructive pulmonary disease
    Frank C Sciurba
    Division of Pulmonary and Critical Care Medicine, Emphysema Research Center, University of Pittsburgh, Suite 1211, 3471 Fifth Avenue, PA 15213, USA
    Proc Am Thorac Soc 3:533-4. 2006
  38. ncbi Positive airway pressure therapy of OSA
    Max Hirshkowitz
    Department of Psychiatry, Baylor College of Medicine, Houston, Texas, USA
    Semin Respir Crit Care Med 26:68-79. 2005
    ..Finally, we present an assortment of approaches for troubleshooting clinical problems commonly encountered among patients being treated with positive airway pressure therapy...
  39. ncbi COPD in the elderly patient
    Nicola A Hanania
    Section of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Baylor College of Medicine, 1504 Taub Loop, Houston, TX 77030, USA
    Semin Respir Crit Care Med 31:596-606. 2010
    ..Lastly, adverse effects from medications prescribed for treatment of COPD may be more pervasive in elderly patients...
  40. ncbi Airway mucus: From production to secretion
    Olatunji W Williams
    Department of Pediatric Medicine and Department of Medicine, Baylor College of Medicine, Michael E. Debakey Houston VA Medical Center, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
    Am J Respir Cell Mol Biol 34:527-36. 2006
    ..As a result, mucin overproduction and hypersecretion are moving away from being markers of disease and toward being testable as functional components of lung disease processes...
  41. ncbi Beta-agonist intrinsic efficacy: measurement and clinical significance
    Nicola A Hanania
    Section of Pulmonary and Critical Care Medicine, Department of Medicine, Baylor College of Medicine and the Houston Veterans Administration Medical Center, Texas 77030, USA
    Am J Respir Crit Care Med 165:1353-8. 2002
  42. ncbi A 4-year trial of tiotropium in chronic obstructive pulmonary disease
    Donald P Tashkin
    David Geffen School of Medicine at the University of California, Los Angeles 90095 1690, USA
    N Engl J Med 359:1543-54. 2008
    ..Previous studies showing that tiotropium improves multiple end points in patients with chronic obstructive pulmonary disease (COPD) led us to examine the long-term effects of tiotropium therapy...
  43. ncbi Risk indexes for exacerbations and hospitalizations due to COPD
    Dennis E Niewoehner
    Department of Medicine at Veterans Affairs Medical Centers in Minneapolis, MN 55417, USA
    Chest 131:20-8. 2007
    ..Our objective was to develop risk indexes for exacerbations and hospitalizations due to exacerbations that might be applied to the individual patient...
  44. ncbi Efficacy of tiotropium inhalation powder in african-american patients with chronic obstructive pulmonary disease
    Gerard J Criner
    Temple University School of Medicine, Temple University Hospital, Philadelphia, PA 19140, USA
    COPD 5:35-41. 2008
    ..In patients of African descent, possible differences have been observed for inhaled beta-agonists. However, pharmacologic responsiveness to a long-acting anticholinergic has not been prospectively evaluated...
  45. ncbi Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology
    James C Hogg
    University of British Columbia iCAPTURE Centre for Cardiovascular and Pulmonary Research, St Paul s Hospital, Vancouver, BC, Canada
    Am J Respir Crit Care Med 176:454-9. 2007
    ..COPD is associated with reduced life expectancy...
  46. ncbi Costs of pulmonary rehabilitation and predictors of adherence in the National Emphysema Treatment Trial
    Vincent S Fan
    VA Puget Sound Health Care System, Health Services Research and Development Center of Excellence, Seattle, WA, USA
    COPD 5:105-16. 2008
    ..A better understanding of patient factors such as socioeconomic status, depression, anxiety and transportation issues may improve adherence to pulmonary rehabilitation...
  47. ncbi On measurement consistency and other hobgoblins
    Max Hirshkowitz
    Sleep 27:847-8. 2004